The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
Jun. 28, 2021
Applicant:
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
Joel Rosenblatt, Pottstown, PA (US);
Issam Raad, Missouri City, TX (US);
Assignee:
Board of Regents, The University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/20 (2006.01); A61K 45/06 (2006.01); A61K 31/21 (2006.01); A61K 31/715 (2006.01); A61K 31/732 (2006.01); C08L 5/00 (2006.01); C08L 5/06 (2006.01); C08L 5/08 (2006.01); C08L 89/00 (2006.01); A61L 29/04 (2006.01); A61L 29/16 (2006.01); A61K 33/40 (2006.01); A61P 31/02 (2006.01); A61D 7/00 (2006.01); A61M 3/02 (2006.01); A61M 25/00 (2006.01); A61M 25/10 (2013.01); A61M 39/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/20 (2013.01); A61D 7/00 (2013.01); A61K 31/21 (2013.01); A61K 31/715 (2013.01); A61K 31/732 (2013.01); A61K 33/40 (2013.01); A61K 45/06 (2013.01); A61L 29/043 (2013.01); A61L 29/16 (2013.01); A61M 3/0262 (2013.01); A61M 3/0283 (2013.01); A61M 25/0017 (2013.01); A61M 25/1011 (2013.01); A61M 39/22 (2013.01); A61P 31/02 (2018.01); C08L 5/00 (2013.01); C08L 5/06 (2013.01); C08L 5/08 (2013.01); C08L 89/00 (2013.01); A61L 2300/404 (2013.01); A61L 2300/406 (2013.01); A61M 2210/0693 (2013.01); A61M 2210/1082 (2013.01); A61M 2210/1089 (2013.01); A61M 2210/12 (2013.01); A61M 2250/00 (2013.01);
Abstract
In some aspects, provided herein are antimicrobial compositions comprising partially esterified polygalacturonic acid and certain fatty acids (e.g., caprylic acid). In some embodiments, the antimicrobial composition may be administered (e.g., topically or orally) to a subject, such as a human patient to treat an infection (e.g., an infection comprising a biofilm). In some aspects, improved catheters are provided.